BB BIOTECH NAM. SF 0,20 (BBZA.DE) Financials
BBZA.DE Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| 2023-12-31 | 2.8 billion | 328.0 million |
| 2023-09-30 | 2.6 billion | 311.7 million |
| 2023-06-30 | 2.6 billion | 315.6 million |
| 2023-03-31 | 2.6 billion | 316.7 million |
BBZA.DE Free Cash Flow and Stock based compensation
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| 2023-12-31 | -998308 | ? |
| 2023-09-30 | 7.6 million | ? |
| 2023-06-30 | 8.9 million | ? |
| 2023-03-31 | 203.8 million | ? |
BBZA.DE Net Income
| Date | Net Income |
|---|---|
| 2023-12-31 | 117.4 million |
| 2023-09-30 | -49.9 million |
| 2023-06-30 | -13.8 million |
| 2023-03-31 | -254.8 million |
BBZA.DE Cash and Debt
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| 2023-12-31 | 538957 | - | - |
| 2023-09-30 | 332217 | - | - |
| 2023-06-30 | 920706 | - | - |
| 2023-03-31 | 761834 | - | - |
BBZA.DE Shares Outstanding
BBZA.DE Expenses
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| 2023-12-31 | - | - | 385123 | 1.7 million |
| 2023-09-30 | - | - | 7.9 million | - |
| 2023-06-30 | - | - | 9.0 million | - |
| 2023-03-31 | - | - | 1.7 million | - |
BBZA.DE Cost of Revenue
| Date | Revenue | Cost of Revenue |
|---|---|---|
| 2023-12-31 | 119.6 million | - |
| 2023-09-30 | -42.0 million | - |
| 2023-06-30 | -4.8 million | - |
| 2023-03-31 | -253.0 million | - |
BBZA.DE
Price: €42.60
Dividend Yield: 0.05%
Forward Dividend Yield: 4.89%
Payout Ratio: -115.64%
Dividend Per Share: 2.07 EUR
Earnings Per Share: -1.79 EUR
P/E Ratio: -28.60
Exchange: GER
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 2.3 billion
Average Dividend Frequency: 1
Years Paying Dividends: 12
DGR3: -3.51%
DGR5: 2.11%
DGR10: 11.48%